These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 26804667)
1. Nasal and ocular responses after specific and nonspecific nasal challenges in seasonal allergic rhinitis. Tomljenovic D; Baudoin T; Megla ZB; Vagic D; Hellings P; Kalogjera L Ann Allergy Asthma Immunol; 2016 Mar; 116(3):199-205. PubMed ID: 26804667 [TBL] [Abstract][Full Text] [Related]
2. Females have stronger neurogenic response than males after non-specific nasal challenge in patients with seasonal allergic rhinitis. Tomljenovic D; Baudoin T; Megla ZB; Geber G; Scadding G; Kalogjera L Med Hypotheses; 2018 Jul; 116():114-118. PubMed ID: 29857893 [TBL] [Abstract][Full Text] [Related]
3. Bet v 1-specific IgA increases during the pollen season but not after a single allergen challenge in children with birch pollen-induced intermittent allergic rhinitis. Keen C; Johansson S; Reinholdt J; Benson M; Wennergren G Pediatr Allergy Immunol; 2005 May; 16(3):209-16. PubMed ID: 15853949 [TBL] [Abstract][Full Text] [Related]
4. Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber. Okuma Y; Okamoto Y; Yonekura S; Iinuma T; Sakurai T; Hamasaki S; Ohki Y; Yamamoto H; Sakurai D Ann Allergy Asthma Immunol; 2016 Aug; 117(2):150-7. PubMed ID: 27263086 [TBL] [Abstract][Full Text] [Related]
5. Mast cell and eosinophil activation during early phase of grass pollen-induced ocular allergic reaction. Jedrzejczak-Czechowicz M; Lewandowska-Polak A; Jarzebska M; Kowalski ML Allergy Asthma Proc; 2011; 32(1):43-8. PubMed ID: 21262097 [TBL] [Abstract][Full Text] [Related]
6. Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber). Hashiguchi K; Tang H; Fujita T; Tsubaki S; Fujita M; Suematsu K; Gotoh M; Okubo K Allergol Int; 2007 Jun; 56(2):125-30. PubMed ID: 17384532 [TBL] [Abstract][Full Text] [Related]
7. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [TBL] [Abstract][Full Text] [Related]
9. Nasal nitric oxide measurements in the assessment of nasal allergen challenge. Tworek D; Kuna P J Investig Allergol Clin Immunol; 2012; 22(2):102-8. PubMed ID: 22533232 [TBL] [Abstract][Full Text] [Related]
10. Nasal corticosteroid treatment reduces substance P levels in tear fluid in allergic rhinoconjunctivitis. Callebaut I; Vandewalle E; Hox V; Bobic S; Jorissen M; Stalmans I; De Vries A; Scadding G; Hellings PW Ann Allergy Asthma Immunol; 2012 Aug; 109(2):141-6. PubMed ID: 22840257 [TBL] [Abstract][Full Text] [Related]
11. Seasonal Local Allergic Rhinitis in Areas With High Concentrations of Grass Pollen. Blanca-Lopez N; Campo P; Salas M; García Rodríguez C; Palomares F; Blanca M; Canto G; Feo Brito F; Rondon C J Investig Allergol Clin Immunol; 2016; 26(2):83-91. PubMed ID: 27164623 [TBL] [Abstract][Full Text] [Related]
12. Laryngeal effects of nasal allergen provocation in singers with allergic rhinitis. Verguts MM; Eggermont A; Decoster W; de Jong FI; Hellings PW Eur Arch Otorhinolaryngol; 2011 Mar; 268(3):419-27. PubMed ID: 21072528 [TBL] [Abstract][Full Text] [Related]
13. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115 [TBL] [Abstract][Full Text] [Related]
14. Nasal treatment with a microemulsion reduces allergen challenge-induced symptoms and signs of allergic rhinitis. Andersson M; Greiff L; Wollmer P Acta Otolaryngol; 2008 Jun; 128(6):666-9. PubMed ID: 18568502 [TBL] [Abstract][Full Text] [Related]
15. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Baroody FM; Logothetis H; Vishwanath S; Bashir M; Detineo M; Naclerio RM Am J Rhinol Allergy; 2013 Jan; 27(1):48-53. PubMed ID: 23406601 [TBL] [Abstract][Full Text] [Related]
16. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165 [TBL] [Abstract][Full Text] [Related]
17. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure. Badorrek P; Müller M; Koch W; Hohlfeld JM; Krug N Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536 [TBL] [Abstract][Full Text] [Related]
18. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis. Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061 [TBL] [Abstract][Full Text] [Related]
19. Inflammatory mediator profiles in tears accompanying keratoconjunctival responses induced by nasal allergy. Pelikan Z Br J Ophthalmol; 2013 Jul; 97(7):820-8. PubMed ID: 23613512 [TBL] [Abstract][Full Text] [Related]
20. Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo. Gilles-Stein S; Beck I; Chaker A; Bas M; McIntyre M; Cifuentes L; Petersen A; Gutermuth J; Schmidt-Weber C; Behrendt H; Traidl-Hoffmann C Clin Exp Allergy; 2016 Oct; 46(10):1355-65. PubMed ID: 27061126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]